- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07369557
Mindfulness-träning under accelererad iTBS för depression (MB-TBS)
MB-TBS: Mindfulness-Based Theta-Burst Stimulation - En pilotstudie som integrerar mindfulness-träning i accelererad neuromodulationsterapi för depression
This NIH-funded single-arm pilot tests the feasibility, acceptability, and preliminary effects of embedding brief guided mindfulness practice (via the Waking Up smartphone app) into the inter-session intervals of clinically administered accelerated intermittent theta-burst stimulation (aiTBS) for major depressive disorder (MDD). Participants receive aiTBS as standard clinical care at MUSC; the research intervention is daily guided mindfulness practice during the aiTBS course. Outcomes include feasibility/acceptability, changes in state mindfulness and hedonic tone (Day 0 to Day 5), perceived ease of meditation, trait mindfulness at 4 and 12 weeks, and durability of antidepressant response (PHQ-9) at 4 and 12 weeks.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
South Carolina
-
Charleston, South Carolina, Förenta staterna, 29407
- Rekrytering
- IOP
-
Kontakt:
- Danyal Smani, MD
- Telefonnummer: 1 843 243 7306
- E-post: claytonolash@gmail.com
-
Charleston, South Carolina, Förenta staterna, 29407
- Har inte rekryterat ännu
- Medical University of South Carolina (MUSC), Brain Stimulation Laboratory Institute of Psychiatry
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Clinical diagnosis of MDD and eligible for aiTBS at MUSC
- Already enrolled in aiTBS course at MUSC
- English proficiency
- Smartphone or willingness to use study-provided device
Exclusion Criteria:
- TMS contraindications (e.g., seizure history, implants, pregnancy)
- Concurrent neuromodulation (ECT, VNS)
- Psychotic disorder, bipolar disorder, active substance use disorder, high suicide risk
- Unable/unwilling to engage in mindfulness or complete questionnaires
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Mindfulness-träning under aiTBS
|
5-15 minutes of mindfulness exercises during aiTBS inter-session intervals (9 total per day) for five consecutive treatment days; optional additional practices allowed. App analytics (with permission) and self-reports quantify engagement. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Feasibility of Guided Mindfulness Practice During aiTBS (Adherence Rate)
Tidsram: Day 0 to Day 5
|
Proportion of participants who complete all mandatory guided practice on each of the five aiTBS treatment days. Calculated as: number completing all five days ÷ total enrolled. Higher values indicate better feasibility. |
Day 0 to Day 5
|
|
Tolerability of Guided Mindfulness Practice During aiTBS (Adverse Events)
Tidsram: Day 0 to Day 5
|
Number and severity of meditation-related adverse events recorded via participant report and study staff observation. Higher values indicate worse tolerability. |
Day 0 to Day 5
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in State Mindfulness (Toronto Mindfulness Scale Total Score)
Tidsram: Day 0 to Day 5
|
Change in Toronto Mindfulness Scale (TMS) total score from baseline to Day 5. Higher scores indicate greater state mindfulness. |
Day 0 to Day 5
|
|
Change in Hedonic Tone (Snaith-Hamilton Pleasure Scale Total Score)
Tidsram: Day 0 to Day 5
|
Change in Snaith-Hamilton Pleasure Scale (SHAPS) total score from baseline to Day 5. Lower scores indicate improved hedonic tone. |
Day 0 to Day 5
|
|
Change in Perceived Ease of Meditation (0-10 Rating)
Tidsram: Day 0 to Day 5
|
Change in meditation ease rating on a 0-10 numeric scale (0 = not at all easy; 10 = extremely easy). Higher scores indicate greater perceived ease. |
Day 0 to Day 5
|
|
Change in Trait Mindfulness (CAMS-R Total Score)
Tidsram: Baseline to Week 12 (with Week-4 assessment)
|
Change in Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) total score from baseline to Week 12. Higher scores indicate greater trait mindfulness. |
Baseline to Week 12 (with Week-4 assessment)
|
|
Durability of Antidepressant Response (Percent Change in PHQ-9)
Tidsram: Baseline to Week 4
|
Percent change in PHQ-9 total score from baseline to Week 4. Lower scores indicate improvement |
Baseline to Week 4
|
|
Meditation Engagement (App Analytics and Self-Report)
Tidsram: Day 0 to Week 12
|
Engagement with the Waking Up app measured by total minutes practiced, number of Foundations completed, and cumulative meditation minutes. Higher values indicate greater engagement. |
Day 0 to Week 12
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Clayton Olash, MD, Medical University of South Carolina
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Pro00148491
- R25DA020537 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Tidsram för IPD-delning
Within 12 months of study completion
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- ICF
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .